Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Polonelli

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Research in Immunology|August 28, 1998
Killer antibodies in fungal infectionsS Conti, W Magliani, P Fisicaro, et al.
Current Medicinal Chemistry|July 29, 2004
Engineered killer mimotopes: new synthetic peptides for antimicrobial therapyW Magliani, S Conti, A Salati, et al.
European Journal of Epidemiology|May 1, 1992
Anaerobic yeast killer systemsL Polonelli, M G Menozzi, L Campani, et al.
Giornale Italiano Di Endodonzia|January 1, 1991
[Diagnostic significance of secretory IgA coated yeast cells in oral candidiasis]L Polonelli, J Ponton, S Frigeri, et al.
Mycopathologia|June 1, 1994
Killer toxin secretion through the cell wall of the yeast Pichia anomalaJ C Cailliez, C Cantelli, N Séguy, et al.
Journal of Natural Products|September 9, 2000
Biological characterization of fusapyrone and deoxyfusapyrone, two bioactive secondary metabolites of Fusarium semitectumC Altomare, G Perrone, M C Zonno, et al.
The Journal of Eukaryotic Microbiology|September 1, 1994
Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxinN Séguy, E M Aliouat, E Dei-Cas, et al.
Medical Hypotheses|September 1, 1994
The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumoniaJ C Cailliez, N Séguy, E M Aliouat, et al.
Molecular Medicine (Cambridge, Mass.)|August 1, 1997
Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis cariniiN Séguy, J C Cailliez, P Delcourt, et al.
The Journal of Infectious Diseases|March 14, 1998
Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodiesS Conti, F Fanti, W Magliani, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Research in Immunology|August 28, 1998
Killer antibodies in fungal infectionsS Conti, W Magliani, P Fisicaro, et al.
Current Medicinal Chemistry|July 29, 2004
Engineered killer mimotopes: new synthetic peptides for antimicrobial therapyW Magliani, S Conti, A Salati, et al.
European Journal of Epidemiology|May 1, 1992
Anaerobic yeast killer systemsL Polonelli, M G Menozzi, L Campani, et al.
Giornale Italiano Di Endodonzia|January 1, 1991
[Diagnostic significance of secretory IgA coated yeast cells in oral candidiasis]L Polonelli, J Ponton, S Frigeri, et al.
Mycopathologia|June 1, 1994
Killer toxin secretion through the cell wall of the yeast Pichia anomalaJ C Cailliez, C Cantelli, N Séguy, et al.
Journal of Natural Products|September 9, 2000
Biological characterization of fusapyrone and deoxyfusapyrone, two bioactive secondary metabolites of Fusarium semitectumC Altomare, G Perrone, M C Zonno, et al.
The Journal of Eukaryotic Microbiology|September 1, 1994
Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxinN Séguy, E M Aliouat, E Dei-Cas, et al.
Medical Hypotheses|September 1, 1994
The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumoniaJ C Cailliez, N Séguy, E M Aliouat, et al.
Molecular Medicine (Cambridge, Mass.)|August 1, 1997
Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis cariniiN Séguy, J C Cailliez, P Delcourt, et al.
The Journal of Infectious Diseases|March 14, 1998
Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodiesS Conti, F Fanti, W Magliani, et al.
Pageof 12